When Sen. Bernie Sanders (I-Vt.) and Rep. Elijah Cummings (D-Md.) opened a probe into huge price hikes for some generic drugs two years ago, an attorney for Heritage Pharmaceuticals wrote the lawmakers that the company had not seen “any significant price increases” for its antibiotic. And Heritage declined to provide any documents.
Now, though, the lawmakers are having trouble believing that explanation.
About the Author Reprints
